We're developing smarter ways to monitor our health and wellbeing for earlier detection and better treatment of injury and disease.
Improving detection and treatment of injury and disease
A key requirement in the advance towards precision health and medicine is our ability to monitor, in real time, the many complex physiological processes occurring within the human body. These processes can show the early warning signs of injury or disease.
If we are able to detect subtle changes in physiological function, disease-specific biomarkers, or exposure to harmful pathogens, we could enable interventions at the earliest moment, improve our understanding of disease progression, and develop more targeted and more efficient treatment options.
Medical devices and systems for real-time monitoring of health and wellbeing
Through our Probing Biosystems Future Science Platform, we are working to develop game-changing medical devices to obtain real-time information about health and wellbeing, and provide health and medical interventions that are timely, customised, and highly specific.
The platform is currently focussed on the areas of diagnostics, theranostics, and wearable and implantable technologies.
In 2019, we announced a $5.1M theranostics research partnership with one of Australia's largest cancer care providers, GenesisCare. Through this project, our scientists will work to develop new theranostic cancer treatments for some of the most difficult-to-treat cancers. This involves identifying the unique signatures of specific cancer cells, and then developing special molecules that can show the exact location of cancer cells and deliver targeted radiation to only those cells. If successful, new treatments could be trialled through GenesisCare's local clinical networks, giving Australian cancer patients earlier access to new treatments.